Harvard Bioscience, Inc.

US$8.36As of Sun 8 Nov 2026, 12:00 UTC
NASDAQ:HBIOHealthcare
Country USA
PE (Fwd) •••
TSR 10Y CAGR (9.99%)
Div yield —
ROE (89.95%)
Medical Instruments & Supplies
Beta (5Y) 1.47
PE TTM —
TSR TTM 61.83%
Mkt cap US$38.06M
ROIC 2.23%
SE Grade™
Value
Quality
Moat
Consensus
Reference
$10
20.64%
453.42%
Hold 4|10|6|4|8
4Q25
1Q26
2Q26
3Q26
Earnings per share$
0.14
0.15
0.14
0.16
4.91%
8.13%
5.64%
12.30%
Revenue$M
3.293
3.422
3.457
3.443
7.72%
9.00%
6.74%
6.10%
Peers (US$38.06M)
Cap (US$)
PE
49.33M
7.920x
30.30M
15.70x
Capital
TTM
5Y
10Y
Leveragex
0.938
0.104
0.100
EBIT/Intx
0.762
0.143
0.149
Own earn%
17.63
(100.72)
(83.30)
Sh yield%
20.14
34.46
31.83
Owners
Insiders/Inst%
11.10
56.10
Short interest%
3.54
SBC / revenue%
5.42
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
4
Op margin range%
0–10
$1 testx
0.1
Incr. ROIC%
3